Fig. 1: Standard testing pathway and current testing pathway with exome sequencing (ES).

CMA chromosomal microarray, DD developmental disability, MCA multiple congenital anomalies.

CMA chromosomal microarray, DD developmental disability, MCA multiple congenital anomalies.